MedPath

Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas

Terminated
Conditions
Anal Fistula
Fecal Incontinence
Surgery
Registration Number
NCT01584752
Lead Sponsor
Central Finland Hospital District
Brief Summary

This is a prospective clinical study on the efficacy of Gore-BioA fistula plug in high transsphincteric fistulas. Follow-up time is six months

Detailed Description

Inclusion criteria for the study is a patient with ultrasound or MRI proven high transsphincteric perianal fistula. Patients with Crohns disease, immunosuppressive medication, anovaginal fistula, radiation therapy or chemotherapy are excluded. A Seton is placed in the fistula track for two months before the application of the plug. Patients are followed up for six months. Symptoms of fecal incontinence before and after intervention are monitored with the Cleveland clinic incontinence score.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age 18-70 years, male or female
  • High cryptoglandular perianal fistula
  • Written approval for the study
  • Sufficient co-operation for the study
  • Localization of the fistula by ultrasound or MRI
Exclusion Criteria
  • Crohns disease
  • Immunosuppressive treatment
  • Anovaginal fistula
  • Radiation therapy 6 months before study
  • Chemotherapy 6 months before study
  • Low- or intersphincteric fistula

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Healing of the fistula6 months
Secondary Outcome Measures
NameTimeMethod
Symptoms of fecal incontinence6 months

Trial Locations

Locations (4)

Helsinki University Hospital

🇫🇮

Helsinki, Finland

Central Hospital

🇫🇮

Seinäjoki, Finland

Oulu University Hospital

🇫🇮

Oulu, Finland

Turku University Hospital

🇫🇮

Turku, Finland

Helsinki University Hospital
🇫🇮Helsinki, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.